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Transgenic Fish - Where We Are and Where Do We Go?
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Abstract
Transgenic fish have been developed that have improved growth, color, disease resistance, sur-
vival in cold, and body composition, and produce pharmaceutical proteins. Transgenes elicit
pleiotropic effects, some positive and some negative. In general, transgenic fish appear to have
lower fitness than controls and pose little environmental risk, but this research is not fully con-
clusive. Transgenic zebrafish with altered coloration have been commercialized and growth hor-
mone transgenic salmon, carp, and tilapia are near commercialization. To enhance commer-
cialization and minimize environmental risk, additional technologies such as transgenic steriliza-
tion need to be developed. Genomic research has produced an abundance of molecular genet-
ic information including many genes for consideration for gene transfer, highly regulated gene
promoters, and knowledge about their expression and function. Functional genomics analysis
should be applied in the future to enhance the capacity and versatility of transgenic technology. 
Preface
Collaboration with Israel has been historically
significant. It is a major component of and has
had major impact on genetic enhancement of
catfish in the United States. Thus, we would
like to begin this manuscript with a heart felt
thanks to Israeli scientists for their assistance,
collaboration, and friendship. The fruitful
cooperation between Auburn University in the
USA and Israeli fish genetics teams (Dor,
IOLR-Haifa, IOLR-NCM-Eilat, and Tel Aviv
University) was initiated 37 years ago, and
has been thriving ever since. In 1969, Dr.
Rom Moav, followed by Dr. Giora Wohlfarth,
visited Auburn University and assisted Dr.
R.O. Smitherman in establishing a catfish
genetics program and a graduate level course
in fish genetics and breeding. Along with Dr.
Smitherman, the Israelis fathered the fish
genetics program at Auburn. About 1975, Dr.
Wohlfarth returned to Auburn as it was in a
major growth phase, and once again assisted
in the research and planning of this phase of
Auburn’s catfish genetics program. In the late
1970s and early 1980s, Dr. Smitherman, Dr.
William Shelton, and Rex. Dunham of Auburn
University collaborated with Dr. Wohlfarth and
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Dr. Gideon Hulata on selective breeding of
farmed fish. As a result of BARD support,
genetically improved fish were produced,
leading to the subsequent increase in use of
genetically improved fish in the USA and
Israeli aquaculture as well as throughout the
world. In the USA, several lines of genetically
improved catfish and tilapia were released.
The first catfish genetics and breeding com-
panies in the USA were spawned from this
collaboration. World-wide, monosex tilapia
production grew from this collaboration. The
USA-Israel collaboration evolved in the late
1980s to include Dr. Rex Dunham, Dr. Tom
Chen, and Dr. Dennis Powers of the USA col-
laborating with Dr. Benzion Cavari, Dr. Wayne
Knibb, and Dr. Boaz Moav working on gene
transfer in farmed fish. Genetic material has
been exchanged, policy on transgenic fish in
the USA evolved, and commercialization of
transgenic fish in the USA is near. The rela-
tionship continued to evolve in the 1990s as
Dr. Zhanjiang Liu joined Auburn University
and teamed with Dr. Dunham and Dr. Boaz
Moav in study of gene transfer in fish.
Hopefully, this valuable and productive rela-
tionship will continue.
Introduction
The foundation for gene transfer research
was laid as early as 1910 when embryologists
experimented with injecting cellular material
into frog eggs (Gurdon and Melton, 1981). By
the early 1970s, it was apparent that gene
transfer technology could provide great insight
into the function of DNA sequences (Gurdon
and Melton, 1981). The first widely publicized
work was the transfer of mRNA and DNA into
mouse eggs (Palmiter et al., 1982). Gordon et
al. (1980) were among the first to microinject
a series of recombinant molecules into the
pronuclei of mouse embryos at the one-cell
stage of development. This pioneering, land-
mark research in mice provided the impetus
for the initiation of genetic engineering
research with fish, which followed 4-5 years
thereafter.
Zuoyan Zhu in the Institute of
Hydrobiology in China was the first to report
a transgenic fish (Zhu, 1985). Twenty years
later, transgenic fish application is on the
verge of making its first and major impact.
GloFish, a transgenic zebrafish, Danio rerio,
containing the fluorescent green, yellow, and
red protein genes (GFP, YFP, and RFP,
respectively) are now commercialized.
Commercialization of transgenic edible fish
was thought to have taken place in some
countries such as Cuba; however, no official
documents are available to confirm this. In
New Zealand commercial brood stock popu-
lations were never used before operations
closed, and Chile plans commercialization.
In North America, marketing of transgenic
salmon may be close, following submission
of an application by A/F Protein, Aqua
Bounty Farms, Waltham, MA, to the US
Food and Drug Administration (FDA) to
obtain approval for selling growth hormone
(GH) transgenic salmon which contain
genetically modified growth hormone genes
(Niiler, 1999). FDA approval for consumption
of these fish is expected in 2006. Aqua
Bounty has potential licensees for their
salmon in the USA, Canada, Chile, and
Europe. In Europe and Japan, conservative
approaches to the development of trans-
genic fish will likely prevail politically for
longer periods of time than in other areas of
the world. Because of these concerns, trans-
genic fish will likely be utilized commercially
to a greater extent in developing countries
than developed countries in the short term
(Bartley and Hallerman, 1995).
Expectations for rapid applications and
impact were unrealistic and have been slowed
by food safety concerns, environmental con-
cerns, lack of research funding, government
regulations, and, just as importantly, the fact
that this technology is not completely a short
term genetic enhancement program but has
many aspects of a long term selection pro-
gram.
There are many aspects of transgenic fish
technology. The areas that will be addressed
in this review are performance traits of trans-
genic fish, pleiotropic effects of transgenes,
fish as biological factories, fitness traits, envi-
ronmental risks, sterilization of transgenic fish,
and the future of this technology.
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Performance of Transgenic Fish
Growth. Positive biological effects have been
obtained by transferring transgenes to fish in
some, but not all, cases and the greatest
amount of work focused on transfer of GH
genes. Due to the lack of available piscine
gene sequences, transgenic fish research in
the mid 1980s used existing mammalian GH
gene constructs. In the early 1990s, most GH
research switched to using fish GH con-
structs. 
Four levels of success have been
obtained for GH gene transfer. In some cases,
no growth enhancement was attained.
Mammalian gene constructs (mMT/rGH)
failed to affect growth of salmonids
(Guyomard et al., 1989ab; Penman et al.,
1991), despite the fact that salmonids are very
responsive to growth stimulation by exoge-
nously administered mammalian GH protein
(McLean and Donaldson, 1993). F1 Nile tilapia
(Oreochromis niloticus) transgenic for a con-
struct consisting of a sockeye salmon metal-
lothionein promoter spliced to a sockeye
salmon growth hormone gene exhibited no
growth enhancement (Rahman et al., 1998),
although salmon transgenic for this construct
show greatly enhanced growth.
Moderate growth enhancement was
reported for some fish species (Zhu et al.,
1986; Enikolopov et al., 1989; Gross et al.,
1992; Lu et al., 1992; Zhu, 1992; Wu et al.,
1994). Gene constructs containing fish GH
sequences driven by non-piscine promoters
elicited growth enhancement in transgenic
carp, catfish, zebrafish, and tilapia (Zhang et
al., 1990; Dunham et al., 1992; Chen et al.,
1993; Zhao et al., 1993; Martinez et al., 1996).
Several species including loach, common
carp, crucian carp, Atlantic salmon, channel
catfish, tilapia, medaka, and northern pike
containing either human, bovine, or salmonid
growth hormone genes grew 10-80% faster
than non-transgenic sibling fish in aquaculture
conditions. Introduction of a CMV-tilapia GH
construct into a hybrid Oreochromis hornorum
resulted in a 60-80% growth acceleration
(Martinez et al., 1996; Estrada et al., 1999)
depending on culture conditions. This was the
first enhancement level obtained.
The next level of enhancement was a 2-6
fold increase in growth from GH transfer. Du et
al. (1992) used an all-fish GH gene construct to
make transgenic Atlantic salmon, and reported
a 2-6-fold increase of the transgenic fish
growth rate. Nile tilapia possessing one copy of
an eel (ocean) pout promoter-chinook salmon
growth hormone fusion grew 2.5-4 fold faster
and converted feed 20% better than non-trans-
genic siblings (Rahman et al., 1998, 2001;
Rahman and Maclean, 1999). Preliminary
results indicated that homozygous transgenic
Nile tilapia produced from the ocean pout
antifreeze-chinook salmon GH construct grew
similar to hemizygous transgenics. Insertion of
other GH constructs into tilapia also yielded
positive results, but not as dramatic as with the
salmon GH constructs. Two possible explana-
tions for the difference in results are the type of
construct and the type of tilapia. Rohu, Labeo
rohita, containing CMV- or B actin-rohu GH
gene had a 4-5 fold increase in growth rate
(Venugopal et al., 2004). Transgenic Atlantic
salmon containing the ocean pout antifreeze
promoter-chinook salmon growth hormone
(GHcDNA1) gene construct had 3-6 fold accel-
erated growth compared to non-transgenic
salmon (Du et al., 1992; Cook et al., 2000a).
Insertion of sockeye MT-B-sockeyeGHcDNA1
(Devlin, 1997) produced a similar result, 5-fold
growth enhancement.
The last level of enhancement involved
hyper levels of growth enhancement. When
introduced into coho salmon, cutthroat trout,
O. clarki, rainbow trout, and chinook salmon,
GH gene constructs using either an ocean
pout antifreeze promoter driving a chinook
salmon GH cDNA or a sockeye salmon met-
allothionein promoter driving the full-length
sockeye GH1 gene elevated circulating GH
levels by as much as 40-fold (Devlin et al.,
1994b; Devlin, 1997), resulting in a 5-30-fold
increase in weight after one year of growth
(Du et al., 1992; Devlin et al., 1994b, 1995ab,
2001) and allowing precocious development
of physiological capabilities necessary for
marine survival (smoltification). The largest of
these P1 transgenics were mated and pro-
duced offspring with extraordinary growth.
Similar results were obtained with mud loach
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(Nam et al., 2001). Transgenic individuals
were 30 times larger than controls. This was
an unusual case as not only did these trans-
genic fish grow faster than normal, they
reached a giant maximum size that was 30
times greater than normal.
Universally, F1 from individual transgenic
fish have highly variable performance, requir-
ing family selection for the development of
high performance transgenic lines. Varying
results among species and families might be
related to different gene constructs, coding
regions, genomic background, chromosome
positions, and copy numbers. Magnification
effects can explain some of the growth differ-
ences between transgenic and control
salmon, however, specific growth rates of the
transgenic coho were approximately 2.7-fold
higher than older nontransgenic animals of
similar size, and 1.7-fold higher than their
nontransgenic siblings (Devlin et al., 2000)
indicating that the transgenic salmon grew at
a faster rate at numerous sizes and life
stages. GH levels increased dramatically
(19.3-32.1-fold) relative to control salmon, but
IGF-I levels were only modestly affected,
being slightly enhanced in one experiment
and slightly reduced in another. 
Domestication is also important in trans-
genic growth responses. Devlin et al. (2001)
first observed that salmonid GH gene con-
structs had a dramatic effect on growth in wild
rainbow trout strains (with naturally low growth
rates) but little or no effect in strains where the
growth rate was enhanced by selection. In
comparison, GH transgenic channel catfish
derived from domesticated and selectively-
bred strains exhibited only moderate growth
enhancement (41%). 
However, additional data on transgenic
rainbow trout (Devlin et al., 2001) refutes this
hypothesis of the effect of wild and domestic
genetic backgrounds on response to GH
transgene insertion. When OnMTGH1 was
transferred to another wild rainbow trout
strain, F77, growth was enhanced 7-fold,
almost 4-fold greater than observed in a non-
transgenic domestic rainbow trout. In this
case, the wild transgenic was actually superi-
or to the domestic selected strain indicating
that genetic engineering can have a greater,
rather than equivalent, effect on domesticated
and selected strains. When F77 was cross-
bred with a domestic strain, growth of the
crossbreed was intermediate to the parent
strains, a typical result (Dunham and Devlin,
1998). However, the transgenic wild x domes-
tic crossbreed was by far the largest geno-
type, 18 times larger than the non-transgenic
wild parent, 13 times larger than the non-
transgenic wild x domestic crossbreed, 9
times larger than the non-transgenic domestic
parent, and more than 2.5 times larger than
the wild F77 transgenic (Devlin et al., 2001).
The combined effects of transgenesis and
crossbreeding had a much greater growth
enhancement effect than crossbreeding or
transgenesis alone. A transgenic with 50% of
its heritage from domestic sources was much
larger than a wild transgenic, so great
response from some domestic genotypes is
possible. As seen in transgenic common carp
and channel catfish, the effect of GH gene
insertion varies among families, and multiple
insertion sites and multiple copies of the gene
were observed. 
Color and reporter genes. The green fluo-
rescent protein gene and other fluorescent
pigmentation genes are currently being stud-
ied to understand development and gene
expression in zebrafish (Amsterdam et al.,
1995; Gong et al., 2002). Zebrafish that glow
in shades of red, green, yellow, and orange
have been developed. 
Disease resistance. Momentum is being
gained in transgenic enhancement of disease
resistance. Expression of viral coat protein
genes (Anderson et al., 1996) or antisense of
viral early genes may improve virus resis-
tance. Resistance against bacterial diseases
may be easier to genetically engineer than for
diseases caused by other classifications of
pathogens. Bacterial disease resistance may
be improved up to 3-4 fold through gene
transfer. Insertion of the lytic peptide cecropin
B construct enhanced resistance to bacterial
diseases 2-4 fold in channel catfish but
caused no pleiotropic effects on growth or
obvious alterations of other traits (Dunham et
al., 2002d). Transgenic and non-transgenic
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full-siblings containing the cecropin B con-
struct were challenged in tanks with
Edwardsiella ictaluri. Both genotypes experi-
enced mortality, but the survival of the trans-
genic individuals was twice that of the con-
trols. Transgenic channel catfish containing
the preprocecropin B construct and their full-
sibling controls experienced a natural epizoot-
ic of columnaris, Flavobacterium columnare.
No cecropin-transgenic fish were among the
mortalities, and only control fish died. 
Similar results were obtained for cecropin
transgenic medaka (Sarmasik et al., 2002). F2
transgenic medaka from different families and
controls were challenged with Pseudomonas
fluorescens and Vibrio anguillarum, killing
about 40% of the control fish by both
pathogens but only 0-10% of the F2 trans-
genic fish by P. fluorescens and 10-30% V.
anguillarum. When challenged with P. fluo-
rescens, zero mortality was found in one
transgenic fish family carrying preprocecropin
B and two families with porcine cecropin P1,
whereas 0-10% cumulative mortality was
observed for five transgenic families with pro-
cecropin B and two families with cecropin B.
When challenged with V. anguillarum, the
cumulative mortality was 40% for non-trans-
genic control medaka, 20% in one transgenic
family carrying preprocecropin B, 20-30% in
three transgenic families with procecropin B,
and 10% in one family with porcine cecropin
P1. Cecropin has also shown anti-viral prop-
erties in vitro. Chiou et al. (2002) examined in
vitro effectiveness of native cecropin B and a
synthetic analog, CF17, for killing several fish
viral pathogens, infectious hematopoietic
necrosis virus (IHNV), viral hemorrhagic sep-
ticemia virus (VHSV), snakehead rhabdovirus
(SHRV), and infectious pancreatic necrosis
virus (IPNV). When these peptides and virus-
es were co-incubated, the viral titers yielded in
fish cells were reduced from several to 104-
fold. Transgenic rainbow trout containing a
synthetic cecropin construct exhibited
increased viral resistance (Thomas Chen,
pers. comm.).
Grass carp, Ctenopharyngodon idellus,
were transfected with carp B actin-human
lactoferrin gene. P1 individuals were more
resistant to Aeromonas, exhibited enhanced
phagocytosis, and were more viral resistance
than controls (Mao et al., 2004).
Shrimp have been genetically engineered
with antisense Taura syndrome virus-coat
protein gene (Lu and Sun, 2005). When chal-
lenged with the Taura virus, transgenic shrimp
had 83% survival and controls had 44% sur-
vival.
Body composition. It is now possible to
directly alter body composition via transgene-
sis. Zebrafish transfected with B-actin-salmon
desaturase genes had enhanced levels of
omega-3 fatty acids, docosahexaenoic acid
(DHA), and eicosapentaenoic acid (EPA) in
their flesh (Alimuddin et al., 2005). 
Cold tolerance. Most efforts in transgenic
fish have been devoted to growth enhance-
ment although there are also reports of
improved cold resistance (Fletcher and
Davies, 1991; Shears et al., 1991). Early
research involved the transfer of the
antifreeze protein gene of the winter flounder
(Fletcher et al., 1988). The primary purpose of
this research was to produce salmon that
could be farmed in arctic conditions, but
expression levels obtained were inadequate
for increasing the cold tolerance of salmon
(Hew et al., 1999). Preliminary results with
goldfish show some promise for increasing
survival within the normal cold temperature
range (Wang et al., 1995). 
Transgenic fish serving as bioreactors.
Transgenic mammals such as cows, goats,
sheep, and rabbits have been used as biolog-
ical factories to produce pharmaceutical com-
pounds and biomedical proteins such as clot-
ting factors and blood thinners. Such technol-
ogy is especially important in the modern
world since human extracted products have
the potential to be contaminated with HIV and
hepatitis viruses as well as other human
pathogens. These products can also be quite
expensive. Transgenically-produced biomed-
ical compounds should be safe from human
pathogens, eventually be less expensive, and
more widely available.
Fish have potential advantages as biore-
actors compared to mammals (Hwang et al.,
2004). These advantages include a short gen-
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eration interval, low costs for maintaining the
animals, easy maintenance, large numbers of
individuals, high density culture, and absence
of mammalian viruses and prions. Several
examples are now available that demonstrate
the potential of fish as bioreactors.
MV-human coagulation factor VII was pro-
duced in transgenic zebrafish, African walking
catfish, and Nile tilapia eggs (Hwang et al.,
2004). Clotting activity was detected indicat-
ing proper post-translational modifications.
Proteins can be collected in eggs or serum, or
possibly different proteins in different tissues
for other types of genes.
Transgenic Nile tilapia secreted human
insulin in Brockmann Bodies (Pohajdak et al.,
2004). Islet tissue was used for xenotrans-
plantation and successfully transferred to dia-
betic nude mice reversing the effects of dia-
betes.
Single chain goldfish luteinizing hormone
(LH) gene was injected into rainbow trout
eggs (Morita et al., 2004). At 4-days of age,
goldfish LH was isolated from the eggs and
the recombinant LH was injected into goldfish.
Testosterone levels in male goldfish were ele-
vated after the injections.
Pleiotropic Effects
Improved feed conversion efficiency is one
pleiotropic effect of GH gene insertion. Fast
growing transgenic common carp and channel
catfish containing rainbow trout growth hor-
mone gene had improved feed conversion
efficiency than controls (Chatakondi, 1995;
Dunham and Liu, 2002). Among common
carp, various transgenic families had
increased, decreased, or no change in food
consumption. Transgenic Nile tilapia had a
20% improvement in feed conversion efficien-
cy, and better used protein and energy than
the controls (Rahman et al., 2001).
Transgenic tilapia expressing the tilapia GH
cDNA under the control of human
cytomegalovirus regulatory sequences con-
sumed about 3.6 times less food than non-
transgenic controls, and food conversion effi-
ciency was 290% better for the transgenic
tilapia (Martinez et al., 2000). Efficiency of
growth, synthesis retention, anabolic stimula-
tion, and average protein synthesis were high-
er in transgenic than control tilapia. Martinez
et al. (2000) observed differences in hepatic
glucose and levels of enzymatic activities in
target organs between transgenic and control
tilapia. Feed conversion efficiency of trans-
genic loach was 50-100% better than controls
(Nam et al., 2004). Increased growth from
genetic enhancement, whether from tradition-
al selective breeding, biotechnology, or gene
transfer, appears to always be a result of both
increased feed consumption and improved
feed conversion efficiency (Dunham, 2004).
The intestinal surface area of GH trans-
genic Atlantic and coho salmon was 2.2 times
that of control salmon and the growth rate was
about twice that of the controls (Stevens and
Devlin, 2000b). The relative intestinal length
was the same in transgenic and control
salmon, but the surface area was greater in
transgenics as a result of an increased num-
ber of folds. Increased gut tissue is a result of
both environmental and genetic effects
(Stevens and Devlin, 2005). 
The insertion of the rtGH gene altered the
survival of common carp (Chatakondi, 1995).
The number of F2 progeny inheriting this
transgene was much less than expected.
Differential mortality, a true pleiotropic effect,
or loss of the recombinant gene during meio-
sis are likely explanations. Remaining trans-
genic individuals had higher survival than con-
trols when subjected to a series of stressors
and pathogens such as low oxygen, anchor
worms, Lernea, Aeromonas, and dropsy.
Conversely, GH transgenic salmon were more
sensitive to Vibrio than controls (Jhingan et
al., 2003). Survival among GH salmon fami-
lies is sometimes improved, sometimes
decreased, and sometimes unchanged rela-
tive to controls (Devlin et al., 2004).
When subjected to low dissolved oxygen
(0.4 ppm), mean absolute survival was the
same for transgenic and control common
carp. However, transgenic individuals had
longer mean survival time than non-trans-
genic full-siblings (Chatakondi, 1995; Dunham
et al., 2002b). Ventilation rate could explain
the slightly better low oxygen tolerance of the
transgenic common carp as the transgenic
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channel catfish with the same rtGH construct
as the common carp had a lower ventilation
rate when subjected to low dissolved oxygen
than the controls (Dunham, unpublished). 
In the case of salmon, GH transgenics had
the same resistance as controls to heat shock
(Jhingan et al., 2003). However, oxygen toler-
ance varied. GH transgenic salmon had an
increased need for dissolved oxygen (Stevens
et al., 1998; Cook et al., 2000bc) but, after
four days of starvation, GH individuals had the
same oxygen uptake as controls (Leggatt et
al., 2003). After feeding, GH transgenics
required 1.4-1.7 fold more O2, even when the
controls consumed an equivalent amount of
feed. Adult transgenics had a higher oxygen
demand, poorer swimming ability, and longer
recovery time compared to ocean ranched
salmon (Lee et al., 2003).
Pleiotropy of the GH gene for oxygen tol-
erance varies from species to species. GH
tilapia (McKenzie et al., 2003) have a 58%
higher metabolism than controls, compensate
for oxygen consumption, and have the same
maximum swim speed as non-transgenics.
GH tilapia tolerate hypoxia equally as controls
despite the higher demand for oxygen.
The GH gene affects body shape. Zhu
(1992) reported an increase in muscle thick-
ness and body width in transgenic common
carp containing the human growth hormone
gene. The effect of rtGH1cDNA (rainbow trout
growth hormone cDNA) on body shape,
dress-out yield, and body composition were
assessed in the F1 and F2 generations of
transgenic common carp (Chatakondi et al.,
1994, 1995; Dunham et al., 2002c). The cor-
relations between head morphometric mea-
surements and length or weight for the F1 and
F2 generations were negative (Chatakondi,
1995), indicating that the fish head does not
grow proportionately to its length or weight.
Various head, body, and caudal traits grew
disproportionately faster than total body
length and this effect was greater in trans-
genic fish in both generations than in control
common carp. Transgenic individuals had rel-
atively larger heads, deeper and wider bodies,
and greater caudal areas than controls.
Similar changes were seen in GH transgenic
Nile tilapia as the head:total length ratio, vis-
cera-somatic index, and hepatosomatic index
were greater in transgenic fish than in control
fish (Rahman et al., 2001). The change in
body shape resulted in a 5% carcass yield for
the transgenic common carp (Dunham et al.,
2002c). 
The condition factor, K, was proportionate-
ly higher in most families of transgenic com-
mon carp (Chatakondi, 1995). However, fam-
ilies 1 and 7 of the F1 generation and families
69 and 70 of the F2 generation had lower con-
dition factors than their controls despite a
higher weight increase, similar to results for
transgenic salmon, because the length
changed more rapidly than the weight in the
transgenic salmon (Devlin et al., 2001).
Transgenic wild-strain rainbow trout had
the slender body shape similar to that of the
wild controls, but their final size at sexual
maturity was much larger than in the non-
transgenic wild rainbow trout (Devlin et al.,
2001), thus no pleiotropic effect on body
shape was seen for these fish. However,
domestic transgenic rainbow trout derived
from a deep-bodied strain, despite minimal
growth enhancement, had an even deeper
body depth than the controls, caused by either
increased muscle or tremendous visceral fat
deposits or both. The altered body shape of
transgenic common carp resulted in improved
dressing percentage in the F2 generation. A
similar result was obtained for transgenic
channel catfish containing the same GH con-
struct.
Excessive levels of growth hormone
resulted in morphological abnormalities in the
head, fin, jaw, and operculum as a result of
excessive cartilage and bone growth of the
fastest growing transgenic salmon (Devlin et
al., 1995a). Insertion of a pOnMTGH1 gene
construct into coho salmon altered centroid
size (Ostenfeld et al., 1998). The dorsal cau-
dal peduncle and abdominal regions were dis-
tinctly enhanced in transgenic fish when com-
pared to controls. Morphological changes of
whole body and syncranium were prominent.
GH gene transgenesis also affects gill
morphology. The gill morphology of trans-
genic Atlantic salmon (Stevens and Sutterlin,
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1999) and Pacific salmon (Stevens and
Devlin, 2000a) differed from that of controls,
but the difference was expressed differently in
the two species. Pacific transgenic salmon
had gill filaments that were similar in length to
the controls, but smaller lamellar spacing.
Atlantic transgenics had longer gill filaments
that were longer than in the controls but simi-
lar lamellar spacing. This illustrates that the
pleiotropic effects from GH transgenesis can
differ, even between closely related species. 
The progeny of salmon that grow 30 times
larger than normal are subviable and virtually
all die. Endocrine stimulation in GH transgenic
salmon is elevated to pathological levels,
causing excessive, deleterious deposition of
cartilage (Devlin et al., 1995ab), analogous to
the mammalian acromegaly syndrome. This
effect can be sufficiently severe such that
impaired feeding and respiration may result in
reduced growth and poor viability.
Consequently, salmon that ultimately display
the greatest growth enhancement as adults
are those that have been only moderately (10
times) stimulated (Devlin et al., 1995ab).
Progeny from transgenic parents with more
moderate accelerated growth do not suffer
reduced survival and increased skeletal
anomalies.
Despite their minimal growth enhance-
ment, domestic GH transgenic rainbow trout
also exhibited cranial deformities (Devlin et
al., 2001). The deformities could be a species-
specific phenomenon. Despite much more
significant growth acceleration compared to
slow growing rainbow trout, GH transgenics,
P1, F1, F2, F3, and F4 GH transgenic common
carp and channel catfish do not exhibit defor-
mities. Additionally, no abnormalities were
apparent in rapidly growing GH transgenic
Nile tilapia, although minor changes to skull
shape were observed in some fish (Rahman
et al., 1998).
GH transgenic fish exhibit body composi-
tion changes, but not as dramatically as mam-
mals. Moisture content in GH transgenic
Atlantic salmon was higher, relative to protein
and ash, than in normal controls (Cook et al.,
2000a). Dunham et al. (2002c) examined
body composition changes in GH transgenic
common carp for two generations, F1 and F2.
The carcass composition of transgenic mus-
cle had a lower percentage of lipids and high-
er protein in both generations (an 7.5%
increase in protein and 13% decrease in fat).
Moisture was lower in F1 transgenic muscle
but unchanged in F2 transgenic individuals.
Transgenic channel catfish with the same
rtGH cDNA also had more protein, less fat,
and less moisture in their edible muscle than
non-transgenic full-siblings (about a 10%
change). Transgenic O. hornorum urolepis
containing the tilapia growth hormone (tiGH)
cDNA had lower levels of cholesterol, free ala-
nine, and aspartic acid in the muscle com-
pared to controls (Martinez et al., 1999). The
increased protein level in transgenic common
carp and channel catfish muscle resulted in
increased amino acid levels. However, the
amino acid ratios and fatty acid ratios were
virtually identical in control and transgenic
common carp and channel catfish, although
some amino acids increased in proportion
slightly more than others. 
GH transgenesis also affects muscle char-
acteristics and activity. GH transgenic catfish
had increased numbers of mitochondria in the
cell, increased numbers of glycogen globules,
increased numbers of muscle fibers, but
reduced numbers of fat globules in their cells.
Muscle fiber size was unchanged. Perhaps
due to the changes in amino acid levels and
ratio and the fat and ultrastructure of the mus-
cle, the flavor and texture of transgenic catfish
flesh was slightly better than in non-trans-
genic controls (Dunham and Liu, 2002.).
Heterozygous growth hormone transgenic
coho salmon had higher numbers of small-
diameter fibers in somite muscles (Hill et al.,
2000). Both the dorsal and lateral region of
the somitic muscle were affected, suggesting
that the transgenic salmon grew by greater
rates of hyperplasia relative to slower growing
nontransgenic fish. Higher levels of activity
were found for phosphofructokinase and
cytochrome oxidase in white muscle of the
transgenic fish, indicating a higher glycolytic
and aerobic requirement in the muscle of
transgenic fish. The GH gene insertion affect-
ed expression of several other genes, and
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many of the additional mRNAs in the trans-
genic fish were specifying myosin light chain
2, consistent with high level of expression in
the early stages of muscle fiber construction.
Additional gene expression changes were
observed in transgenic GH salmon (Ettensohn
et al., 2004). Complement factor Bf-2 was
down-regulated. Methionine adenyltrans-
ferase was up-regulated. Myostatin 1 was not
affected (Roberts et al., 2004). Myostatin 2
was down-regulated in white muscle, but up-
regulated in red muscle. Myostatin immunore-
active protein (MIP) decreased indicating
decreased processing. These changes in
myostatin expression and MIP may be partial
explanations for the hyper growth in GH
salmon. The level of digestive enzymes was
relatively unchanged in GH salmon and does
not explain the altered growth.
Color changes in GH transgenic coho
salmon (Devlin et al., 1995b; Devlin 1997).
Individuals containing opAFP or OnMT
salmon GH constructs have lighter skin pig-
mentation and this is a reliable marker for
identifying transgenic salmon prior to first
feeding (Devlin et al., 1995b). Control fish
possessed the normal brown coloration typi-
cal of coho salmon alevins, whereas the GH
transgenics had a distinct green coloration.
The most important pleiotropic effect,
which is one of the major explanations for the
growth differences in transgenic and control
salmon, is the accelerated smoltification of the
transgenics. The transgenics smolt up to two
years early and display enhanced silver col-
oration and osmoregulatory ability (Devlin,
1997).
In general, the larger the direct effect, the
larger and more dramatic the pleiotropic effect
for GH transgenic fish. This may or may not
be the case for insertion of other genes. GH
affects a large number of biochemical path-
ways and this could be an extreme example of
pleiotropy in transgenic fish.
Environmental Risks and Fitness Traits
Commercialization of transgenic aquatic
organisms on a large scale may have a vari-
ety of ecological implications (Hallerman and
Kapuscinski, 1992, 1993). Escape of trans-
genic aquatic organisms will eventually occur
from a commercial facility, and the range of
receiving ecosystems is broad.
The risks of transgenic fish should be sim-
ilar to the risks of domestic fish. Most data
indicate that wild fish are more competitive
than domestic fish (Dunham, 1996), resulting
in elimination of the domestic fish and their
potential positive or negative impacts. Utilizing
AFLP analysis, Simmons et al. (2006) deter-
mined that domestic populations of channel
catfish in Alabama, USA, have had no genet-
ic impact on wild populations. However,
recent salmonid research indicates that there
are situations where domestic fish can have
genetic impacts on wild populations. When
repeated large-scale escapes of domestic fish
occur, genetic impacts can occur from the
sheer force of numbers. Transgenic fish
would make an impact in this scenario but,
again, the consequences should not vary
much from that of fish genetically altered by
other means.
Reproductive performance, foraging abili-
ty, swimming ability, and predator avoidance
are key factors that determine the fitness of
transgenic fish and should be standard mea-
surements prior to commercial application.
Most available data indicate that transgenic
fish are less fit than non-transgenic fish and
likely to have little if any environmental
impact. Extremely fast growing salmon and
loach have low fitness and die (Devlin et al.,
1994b, 1995ab). 
Several models have been developed that
estimate and indicate the genetic risk of trans-
genic fish. Muir and Howard (1999) evaluated
a model and created the term ‘Trojan gene
effect’, i.e., the extinction of a population due
to the mating preference for large transgenic
males that have reduced fitness, thus placing
a severe genetic load on the population. Their
conclusion was that both reduced fitness and
increased fitness have potential adverse eco-
logical effects. This modeling was based on
experimental results with medaka in aquaria. 
Hedrick (2001) developed a deterministic
model for the case in which a transgene has a
male-mating advantage and a general viabili-
ty disadvantage, analogous to the Trojan
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gene effect of Muir and Howard (1999).
Hedrick’s results indicate that in 66.7% of the
possible mating and viability combinations,
the transgene invades the natural population
and increases in frequency, while in 50% of
the combinations, the transgene goes to fixa-
tion. The increase in the frequency of the
transgene reduces the viability of the natural
population, increasing the probability of
extinction of the natural population.
Based on data from a laboratory popula-
tion of medaka harboring a regulatory
sequence from salmon fused to the coding
sequence for human growth hormone, Muir
and Howard (2001) again concluded that a
transgene can spread to a wild population
even if the gene markedly reduces a compo-
nent of fitness. In juvenile transgenics, the
growth rate increased while survival dropped,
resulting in changes in the development rate
and size-dependent fecundity of females.
Important factors in the model were the prob-
ability of various genotypes mating, the num-
ber of eggs produced by each female geno-
type, the probability that the eggs will be fertil-
ized by the sperm of each male genotype
(male fertility), the probability that an embryo
will be a specific genotype given its parental
genotypes, the probability that the fry will sur-
vive, and parent survival. Muir and Howard’s
(2001) interpretation was that transgenes
would increase in populations despite high
juvenile viability costs if transgenes had suffi-
ciently high positive effects on other fitness
traits. Sensitivity analyses indicated that
transgene effects on age at sexual maturity
would have the greatest impact on transgene
allele frequency. Juvenile viability had the
second greatest impact. However, a defect in
the simulation was the fact that the effect of
predation in the wild could not be included in
the model, biasing viability estimates (Muir
and Howard, 2001).
Although these modeling experiments
based on laboratory data on small model
species illustrate potential risk of transgenic
fish, some weaknesses exist. The environ-
ment was artificial, the mating preference
does not exist for many fish including catfish,
the models do not account for genotype-envi-
ronment interactions which are likely, preda-
tion is absent as Muir and Howard (2001) indi-
cate and the overall performance of the fish is
not accounted for.
Body size does not necessarily result in
mating advantages. Rakitin et al. (2001) uti-
lized allozymes and minisatellites to deter-
mine that male size, condition factor, and total
or relative body-weight loss over the season
were not correlated with the estimated propor-
tion of larvae sired by each Atlantic cod male
during the spawning season. Similar results
were observed in salmon (Doyle, 2003).
However, Atlantic cod male reproductive suc-
cess was affected by female size, with males
larger (>25% total length) than females siring
a smaller proportion of larvae (Rakitin et al.,
2001). In this case, large size was reproduc-
tively disadvantageous. 
In some cases, reproductive traits have
not been greatly affected by GH transgenesis;
in others, they have been adversely affected.
Fast growing transgenic tilapia have reduced
sperm production. Transgenic channel catfish
and common carp have similar reproduction
and rates of sexual maturity compared to con-
trols (Dunham et al., 1992; Chen et al., 1993;
Chatakondi, 1995). Spawning success in
transgenic channel catfish and controls
appeared similar. When the two genotypes
were given a choice in a mixed pond, mating
was random and spawning ability was equal
(Dunham et al., 1995). Fecundity is not affect-
ed by inserting rainbow trout GH cDNA in
common carp. Precocious sexual develop-
ment was not observed in transgenic common
carp. However, GH transgenic male tilapia
had reduced sperm production. Female GH
transgenic Nile tilapia had a lower gonadoso-
matic index than non-transgenic siblings in
both mixed and separate culture conditions
(Rahman et al., 2001). The gonadosomatic
index in transgenic males was higher in mixed
culture and lower in separate culture than in
their non-transgenic siblings. Zebrafish con-
taining fluorescent pigment genes had unal-
tered or lower reproduction (Gong et al.,
2003). 
Reproduction is a complicated trait in
salmon. Mating success is not determined by
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size alone but is also affected by color, body
shape, courtship, competition, physiology,
migration ability, environmental effects, and
genotype-environment interactions. GH
salmon attain normal adult body size and
have advanced hatch time and early growth
(Devlin et al., 2004). GH salmon had early
sexual maturity (one year) in the laboratory,
but the age of maturity in the wild is unknown
(Bessey et al., 2004). Transgenic rainbow
trout experienced early maturation at 2 years
of age, but in the same season as the con-
trols. In the laboratory, there was no
enhanced adult size, cultured salmon had
higher spermatocrits than transgenics and
“wild hatchery fish”, transgenics had lower
spermatocrits than controls, and milt was
equally competitive among transgenic control,
cultured, and wild hatchery fish,. However,
use of transgenic milt resulted in a lower
hatch. GH transgenics had lower spawning
and courtship behavior and higher fecundity,
but smaller eggs.
Transgenic fish could be more competitive
in seeking feed. Devlin et al. (1999) examined
the ability of F1 coho salmon (250 g) contain-
ing a sockeye metallothionein-B promoter
fused to the type 1 growth gene-coding region
to compete for food through higher feeding
motivation. Transgenic coho salmon con-
sumed 2.5 times more contested pellets than
the controls; the transgenic fish consumed 2.9
times more total pellets than the non-trans-
genic controls, indicating a high feeding moti-
vation of the transgenic fish. The shortcom-
ings of this trial were that it was conducted in
a highly artificial environment with a type of
food that will not be encountered in natural
conditions. The food-seeking aggressiveness
is a likely factor for the increased vulnerability
to predation. Similarly, transgenic tilapia out-
competed controls for artificial food (Guillen et
al., 1999). Transgenic tilapia had a larger
appetite than the controls. Interestingly, wild
tilapia out-competed domestic tilapia for food.
An important factor in all these experiments
was that the fish competed for artificial, not
natural, food.
Genotype-environment interactions are
important and occur for growth of transgenic
channel catfish (Dunham et al., 1995).
Transgenic channel catfish containing
salmonid growth hormone genes grew 33%
faster than normal channel catfish in aquacul-
ture conditions with supplemental feeding.
However, there was no significant difference
in growth performance between transgenic
and non-transgenic channel catfish in ponds
without supplemental feeding, indicating
equal foraging ability and the inability of trans-
genic catfish to express their growth potential
with limited feed (Chitmanat, 1996). When
grown under natural conditions where food is
limited, the transgenic channel catfish had a
slightly lower survival than the control and
grew at the same rate as the non-transgenic
controls. The lower survival may have been
due to starvation. Transgenic Atlantic salmon
had higher metabolic rates and lost protein,
dry matter, lipid, and energy more quickly than
controls (Cook et al., 2000a).
The foraging ability of transgenic and con-
trol catfish is similar under conditions of com-
petition and natural food sources and, as is
the case for most genetic improvement pro-
grams, genetically engineered fish need ade-
quate food to express their potential.
The faster growing transgenic fish could
have impaired swimming, leading to predator
vulnerability, problems in capturing prey,
reduced mating ability for some species, and
reduction in competitiveness for any trait
requiring speed. Selection for swimming abili-
ty may be one of the primary mechanisms lim-
iting the genetic increase in fish size and pre-
venting fish from evolving to larger and larger
sizes. 
Silversides, Menidia menidia, from Nova
Scotia ate more food, had more efficient feed
conversion, and grew faster than a population
from South Carolina (Billerbeck et al., 2001a).
However, the Nova Scotia strain was more
vulnerable to predation than the South
Carolina strain and predation increased with
growth rate and feeding rate both within and
between strains (Billerbeck et al., 2001b).
Maximizing energy intake and growth rate
entails fitness costs in the form of increased
vulnerability to predation (Doyle, 2003).
Predator avoidance was slightly better for
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non-transgenic than transgenic channel cat-
fish fry and fingerlings exposed to largemouth
bass, Micropterus salmoides, and green sun-
fish, Lepomis cyanellus, (Dunham, 1995;
Dunham et al. 1995, 1999). GH transgenic
salmon have reduced swimming ability (Farrell
et al., 1997; Stevens et al. 1998) and lack of
fear of natural predators (Abrahams and
Sutterlin, 1999). GH salmon are willing to take
greater risks in the presence of predators and
are aggressive feeders. However, predator
avoidance data is conflicting (Devlin et al.,
2004; Vandersteen Tymchuk et al., 2005). Age
and genotype-environment interactions
appear to be important in predator avoidance
studies of GH transgenic salmon (Devlin et al.,
2004). Fastest and slowest growing individu-
als were eaten in some, but not all, experi-
ments and this might be related to age effects.
The design of an environmental risk/preda-
tion study is important. Results could be affect-
ed by the habitat or whether artificial or natural
food is provided. Selection of same-sized fish
to initiate experiments could alter the genetic
make-up of the populations and their behavior.
The length of the experiment is important. In
some cases, salmon GH experiments were
conducted for only two days. Dunham et al.
(1986) demonstrated significant genotype-
environment interaction based on the length of
the experiment for hybrid and crossbred catfish
in angling vulnerability experiments.
On an absolute speed basis, transgenic
coho salmon swam no faster at their critical
swimming speed than smaller non-transgenic
controls, and much slower than older non-
transgenic controls of the same size (Farrell et
al., 1997). Ostenfeld et al. (1998) found that
coho salmon containing pOnMTGH1 had an
altered body contour, centroid size, enhanced
caudal peduncle, and enhanced abdominal
regions compared to controls. The most
prominent alterations were the change in the
syncranium and the less elliptical head of the
transgenic fish. The overall body shape was
less fusiform for transgenic coho salmon.
Therefore, the decrease in swimming ability
may have been the result of a loss of hydro-
dynamics and increased drag coefficient
caused by the altered body shape. This
change in body shape might also have altered
the leverage or efficiency of the muscle move-
ments for swimming. The inferior swimming
ability of the transgenic salmon should cause
them to have inferior abilities to avoid preda-
tors, capture food, and migrate to the sea and
return to reproduce in natural settings. 
All transgenic fish evaluated to date have
fitness traits that are either the same or weak-
er than the controls. The increased predator
vulnerability, reduced swimming ability, lack of
increased growth when foraging, and
unchanged spawning percentage of the trans-
genic fish indicate that some may not com-
pete well under natural conditions, or cause
major ecological or environmental damage.
Although transgenic fish may be released into
nature unintentionally, ecological effects
should be unlikely because of reduced fitness. 
The greatest environmental risk that a
transgenic fish would have is when the gene
insert would allow the transgenic genotype to
expand its geographic range, essentially
becoming equivalent to an exotic species.
About 1% of exotic releases result in adverse
environmental consequences (Welcomme,
1988). Altering temperature or salinity toler-
ance would be analogous to development of
an exotic species since this would allow the
expansion of a species outside its natural
range. This type of transgenic research and
application should be avoided. Antifreeze pro-
tein genes from winter flounder have been
introduced into Atlantic salmon in an attempt
to increase their cold tolerance (Shears et al.,
1991). If this research were successful, a real
possibility of environmental impact would
exist. Similarly, if tilapia were made more cold
tolerant, a strong possibility of detrimental
environmental impact would exist.
Transgenic Sterilization
Data to date indicate that transgenic fish have
inferior fitness traits needed for successful
establishment if accidentally introduced into
the natural environment. Likely, the most
desirable transgenic genotypes for aquacul-
ture will be strongly selected in natural set-
tings. The greater the phenotypic change in
target traits such as growth rate, the greater
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the pleiotropic effects on other traits including
fitness traits such as predator avoidance and
swimming ability and the lower the probability
of genetic impact on wild populations. In real-
ity, transgenic fish may be a more acceptable
aquaculture genotype than traditional domes-
tic fish, as high performance transgenics may
be eliminated in the natural environment more
rapidly than other types of domestic fish,
reducing the impact on native populations. 
However, it will be difficult to prove this
hypothesis without an actual escape. Even
with strong data indicating the likelihood of
low or negligible environmental risk, many
governments will be reluctant to allow com-
mercialization of transgenic fish because of
public perception and pressure from the
media and environmental groups. Therefore,
confinement will be necessary for approval for
commercialization. However, most physical,
chemical, and biological confinement options
are not 100% failsafe. A potential key confine-
ment option is development of genetic steril-
ization. Successful genetic sterilization elimi-
nates almost all environmental issues con-
cerning application of transgenic fish.
Polyploidy has been proposed as one way
to achieve genetic sterilization, however, this
approach has drawbacks. Triploid induction is
not commercially feasible for all species, it is
not always 100% effective, it requires fertile,
diploid brood stock, and it has adverse effects
on some economic traits, partially negating
some of its improved performance. Both
transgenic triploid salmon (Jhingan et al.,
2003) and transgenic triploid tilapia (Dunham,
2004) have substantially reduced growth com-
pared to diploid transgenics, although growth
of triploid transgenics is still much higher than
that of controls. Transgenic loach triploids had
slightly lower early survival than diploids (Nam
et al., 2004).
Redundant mechanisms could be another
option for genetic sterilization. Nam et al.
(2004) attempted to sterilize transgenic loach
by combining triploidy and hybridization. This
had adverse effects on growth. Transgenic
diploid loach were 30 times bigger than
diploids, hybrid diploids, and triploid hybrids.
However, transgenic interspecific hybrids and
triploid interspecific hybrids were only 14
times larger than the same three non- trans-
genic controls.
Transgenic sterilization has the potential
to render transgenic fish sterile without the
drawbacks of polyploidy. Transgenic steriliza-
tion would almost completely eliminate envi-
ronmental risks and may be the most impor-
tant key to commercialization of transgenic
fish. Still, some argue that the potential would
exist for escaped transgenic sterile fish to dis-
rupt mating of wild conspecifics, potentially
reducing the population. Massive escape
could lead to such a scenario. However,
unless repeated large-scale escapes occur,
this effect would be temporary. Perfect con-
finement is not possible for all applications of
transgenic fish. However, the combination of
drastically reduced fitness of domestic trans-
genic fish, genetic sterilization, transfer of
appropriate gene constructs, and appropriate
physical confinement wound reduce the risk
to such a negligible level that the benefits
would be much greater than the risks. 
Preliminary research on transgenic steril-
ization has been promising but this technolo-
gy is yet to be perfected. Carp β actin-tilapia
salmon type GnRH antisense construct was
injected into Nile tilapia (Norman Maclean,
pers. comm.; Dunham, 2004). Transgenic
females were crossed with wild-type males; a
reduction in fertility of about half that of non-
transgenic control females was observed.
Fertility was much more greatly reduced in
transgenic males crossed to control females.
In some cases, 0% fertility was obtained with
an average reduction of about 80% in fertility.
Limited data on transgenic females crossed
with transgenic males indicated near zero fer-
tility.
Tilapia β actin-tilapia seabream GnRH
antisense construct was injected into Nile
tilapia without reduction in fertility of heterozy-
gous transgenic males and females. Limited
data on transgenic females crossed with
transgenic males indicated no reduction in fer-
tility. Reciprocal crosses between seabream
and salmon GnRH antisense transgenics
gave hatch rates that appeared to be dictated
by the salmon GnRH antisense parent. 
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Transgenic rainbow trout containing
salmon type antisense GnRH from Atlantic
salmon, Salmo salar, driven by either the
GnRH or histone 3 promoter had reduced lev-
els of GnRH and appeared to be sterile
(Uzbekova et al., 2000ab). Preliminary data
indicated that spermiation of transgenic males
was only obtained after prolonged treatment
with salmon pituitary extract, whereas control
males spermiated naturally. Data is still need-
ed for the females. 
Another strategy, introduction of “Sterile
Feral“ constructs, disrupts embryonic devel-
opment, thus sterilizing brood stock.
Preliminary results show promise for this
approach (Thresher et al., 2001). Deformities
and mortalities were produced with several of
the constructs. Gene expression was
reversibly repressed with utilization of the
doxycycline. 
The percentage of deformed zebrafish
embryos injected with 3’-zBMP2 and 5’-
zBMP2 dsRNA was 43.4% and 40.2%, as
compared to 9.2% and 2.4% in the corre-
sponding controls. Linearized pzBMP2-As-
EGFP anti-sense injected into one-cell
zebrafish embryos gave up to 33% deformed
embryos. pzBMP2-ds injected into 1-4 cell
stage embryos gave up to 45% deformed
embryos. pBIT(smad)-BMP2ds resulted in
39% deformed embryos without dox, and 18%
deformed individuals with dox. pBIT(smad)-
BMP2 sense produced 35% deformed
embryos. In these experiments controls yield-
ed 0-10% deformed individuals.
The same approach was utilized in oys-
ters. The promoter was Drosophila heat shock
protein. The developmental genes for which
knockout blockers were developed were the
Hox genes controlling a cascade of develop-
mental events. Reporter genes such as green
fluorescence protein were used to screen for
positive individuals and test for gene expres-
sion, repression, and reversibility. Larval oys-
ters injected with HoxCG1 double stranded
(DS) RNA had arrested development (79%
failed to develop to the D-hinge larval stage).
Arrested development occurred in 67% and
33% of oyster embryos transfected with
pHSP-oHoxDS/BH plasmid when heat shock
or no heat shock was applied, respectively.
When the same experiment was conducted
with the tetracycline-responsive plasmid
phsp-BiT-RFP/dsRNA-HoxCG1, 67% of the
oysters had arrested development without dox
treatment and 9% had arrested development
with dox treatment. GFP and dsRNA-zfBMP
transfected oyster embryos expressed green
fluorescent protein and had 30% mortality.
With the addition of dox, there was no expres-
sion of GFP and mortality was dropped to 5%,
demonstrating the potential of the Tet-OffTM
system. In all these experiments, controls had
0-5% deformities.
One hundred percent deformities and
mortalities were not achieved. This was not
surprising as not all embryos would have
received the genes, and those that did would
be mosaics of varying degrees with variable
numbers of transgenic cells in the P1 genera-
tion. The reporter genes may also have com-
plicated expression.
Templeton (2005) evaluated some of these
same zebrafish constructs, SF3(zSMad5 pro-
moter/Bmp2 promoter/dsBmp2 gene and
SF4(zSMad5 promoter/Bmp2 promoter/zBmp2
gene), in channel catfish. Similar to the
zebrafish results, electroporation of these con-
structs killed channel catfish embryos, and a
substantial percentage of embryos could be
rescued by administration of doxycycline.
Where Do We Go?
Transgenic fish with improved color, growth,
disease resistance, and body composition as
well as transgenic fish capable of producing
biodmedical proteins have been produced.
Where do we go from here? 
Increased research will be needed to
model environmental risks, measure fitness
and actual environmental risks, and deter-
mine food safety for commercialization and
application of past and future progress.
Success and application of transgenic fish
will be dictated by the successful demonstra-
tion of food safety, lack or potential lack of
environmental risk, appropriate government
regulation and labeling, public education, and
development of genetic sterilization for trans-
genic fish. Initial surveys indicate that the
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general population in many countries does
not understand biology and food production.
This could exasperate marketing of trans-
genic fish products that are proven safe,
although many food products partially derived
from transgenic plants are currently being
marketed in the USA without great public out-
cry. When appropriate, well-executed public
education may be necessary to obtain broad
consumer acceptance of transgenic fish from
environmental and food safety standpoints
and, perhaps, regarding how “organic” a
transgenic fish may be. If transgenic steriliza-
tion technology is developed that is reversible
upon demand, the above application issues
will greatly decrease in importance and, in
some cases, be fully addressed. Increased
emphasis needs to be placed on transgenic
sterilization research.
Initial experiments indicate the possibility
of controlling reproduction via transgenesis.
Future success in this area would potentially
have one of the greatest impacts from recom-
binant DNA technology. This approach could
solve not only many transgenic issues but
many biodiversity and genetic biodiversity
issues as it would allow environmentally safe
application of transgenic fish, interspecific
hybrids, domestic fish in general, exotic
species, and utilization of wild conspecifics
outside their native watershed for recreational
applications without genetic consequences.
Transgenic fish research and application
of transgenic fish has not progressed as
rapidly as many envisioned when research on
transgenic fish began about 21 years ago. We
need to address some of the key reasons for
the perceived slowness of this research and
its application. As for many other research
areas and in particular aquaculture and aqua-
culture genetics research, lack of funding has
been one problem that hindered progress.
This is a difficult problem to address, but com-
munication and education such as this BARD
workshop are one of the few mechanisms that
may open the doors to more funding in the
future. Public education and support are key
as well. 
Lack of control over where transgenes are
inserted in the genome and other possible
genetic factors such as genetic background
and epistasis have lead to various responses
in individual transgenic families or lines. This
dictates combining transgenesis with tradi-
tional techniques such as selection to identify
high performance transgenic lines and opti-
mize their gene expression and phenotype.
This makes gene transfer a medium to long-
term, rather than short-term, breeding pro-
gram. As for traditional selective breeding pro-
grams, most research institutes and scientists
do not have the facilities, commitment, or
patience for relatively long experiments that
are further aggravated by the potentially con-
troversial nature of the research. Long-term
commitment is needed to allow transgenic fish
technology to reach fruition.
Some transgenic technologies have not
been pursued for fish because of a lack of
embryonic stem cell lines for fish. This has
hindered efforts to conduct gene knockout
research and homologous recombination.
However, transplantation of primordial germ
cells is now possible (Takeuchi, 2003), open-
ing the door to new gene knockout technolo-
gy. New targeted gene insertion and gene
knockout technologies are on the horizon (Cui
et al., 2003) to alleviate these problems.
Early work in transgenic fish was also hin-
dered by a lack of fish promoters and much
was conducted with viral promoters. If com-
mercialization is the objective, much of that
early research needs to be repeated, examin-
ing expression with fish promoters that will
likely receive much better public perception
and marketability. The advancement in
genomics will not only provide important
genes for gene transfer that likely will have
greater public acceptance, but also highly reg-
ulated promoters. 
Similarly, inducible and tissue specific
expression is likely needed for better trans-
gene expression and performance in the
future. Progress is being made as several tis-
sue specific promoters have been developed
from zebrafish (Gong et al., 2002) including
epidermis specific keratin 8, fast muscle spe-
cific myosin light polypeptide 2, and pancreat-
ic exocrine cell specific elastase B. For some
applications, inducible promoters may be
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desirable to allow induction of transgene
expression at specific developmental life
stages. The inducible HSP70 gene that
encodes an enzyme playing an essential role
in protein metabolism has been isolated and
characterized from O. mossambicus; it dra-
matically increased the rate of mRNA tran-
scription when fish were exposed to transient
heat shock (Molina et al., 2000). 
Currently, the largest global research
activity relevant to current and future trans-
genic research is genomics and functional
genomics. Much smaller research efforts exist
for gene transfer and transgenic application in
fish, and research funding for this area is
much smaller than for genomics. Much is
being learned about genetic mechanisms and
gene expression regarding the physiology,
response to stressors, and response to envi-
ronmental variables by fish. Great progress
has been made regarding gene expression
and regulation, gene isolation and sequenc-
ing, and gene mapping.
Financial support waned for transgenic
research partially because of controversy sur-
rounding the technology and the advent,
importance, need for research dollars, and little
or no perception of controversy associated with
genomics. In some ways, this was actually
support for a needed branch of transgenic
technology. A huge amount of genomic infor-
mation has been generated and it is growing
rapidly. How are we going to use and apply the
knowledge of genomics and functional
genomics in the near future? One potential out-
put is that the increased understanding in
physiology could lead to new environmental
interventions and management in fish culture.
This information could allow for the develop-
ment of and enhancement of marker assisted
selection programs. One of the most promising
applications of this explosion in genomics is
through transgenic technology. In some ways,
research support for genomics has been
research support for transgenic technology. 
Important aquaculture traits such as toler-
ance of poor water quality, harvestability, car-
cass yield, increased reproduction, and
improved utilization of plant resources have
yet to be addressed by transgenic technology.
Basic information from genomic research may
be the starting point to effectively addressing
genetic enhancement of these traits.
One of the greatest future potential bene-
fits of gene transfer in fish will be enhance-
ment of disease resistance. In general, dis-
ease is the greatest problem facing aquacul-
ture and damaging its profitability. Additionally,
this should be an animal welfare issue.
Transgenic fish with enhanced disease resis-
tance would increase profitability, production,
efficiency, and the welfare of cultured fish.
Preliminary research indicates great promise
for enhancing disease resistance. Genetic
gains are possible through traditional selective
breeding, but it appears that the rate of genet-
ic improvement and the consistency of genet-
ic improvement may be greater with the trans-
genic approach (Dunham et al., 2002ad).
Selective breeding may also have the draw-
back that diseased organisms may respond to
selective forces as well, negating some of the
selection response in the fish.
One of first applications of transgenics in
fish was the alteration of color in ornamental
and aquarium fish with fluorescent pigment
genes. If consumers demand color-altered
transgenic fish, this could evolve into a major
application of transgenesis with a large eco-
nomic impact. This may also result in addi-
tional environmental risk issues and confine-
ment issues. Many, but not all, ornamentals
cannot survive in the natural environment.
Large aquaculture facilities can be monitored
to ensure adequate confinement but it will be
impossible to monitor and confine thousands
or millions of households. Therefore, new
issues and perspectives might need to be
addressed. 
A topic that is generally avoided is the
application of transgenic fish in recreational
fisheries. This would involve release of trans-
genic fish in unconfined areas and confined
urban environments. Public opinion will vary in
regards to this application. The growth rate
and aggressiveness demonstrated for some
transgenic fish may be desirable in sport fish
applications. Some fishermen are purists and
would never want to fish for a genetically mod-
ified fish of any type. Other fishermen have
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expressed interest in the possibility of geneti-
cally modified trophy fish. Some fishermen are
unconcerned by the above scenarios/issues;
their objective is to have a successful fishing
trip, in other words, an acceptable catch per
effort rate. Application of transgenic fish in
aquaculture and ornamental fish will likely
occur much earlier than any recreational fish-
eries application.
The ultimate aquaculture genotype will
likely be developed by combining genetic
enhancement programs. In Israel, Hinits and
Moav (1999) were able to improve common
carp growth by genetic engineering together
with crossbreeding more than by crossbreed-
ing alone. Similarly, when salmon metalloth-
ionein promoter/salmon GH1 cDNA,
OnMTGH1 was transferred to another wild
rainbow trout strain, F77, growth was
enhanced 7-fold, almost 4-fold more than a
domestic rainbow trout (Devlin et al., 2001).
The transgenic wild x domestic crossbreed
was by far the largest genotype, 18 times larg-
er than the non-transgenic wild parent, 13
times larger than the non-transgenic wild x
domestic crossbreed, 9 times larger than the
non-transgenic domestic parent, and over 2.5
times larger than the wild F77 transgenic
(Devlin et al., 2001). Combined transgenesis
and crossbreeding had much greater growth
enhancement effects than crossbreeding or
transgenesis alone. Channel catfish trans-
genic for rainbow trout GH had moderate
growth enhancement (41%) and were derived
from domestic, selectively bred catfish. More
research is needed that addresses taking
advantage of multiple genetic enhancement
programs.
Genetics is no silver bullet. Genetics of
aquaculture organisms and production can
and will always need improvement. We may
never reach the ultimate genotype of cultured
fish and shellfish, but improvements will
definitely be made with genetic research.
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